Response of cultured normal canine mammary epithelial cells to deracoxib-doxorubicin combination.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Acta Veterinaria Hungarica

• Publication date

  2017-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1556/004.2017.035PMID 28956484
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27

  2016influential reference
• Potency of non-steroidal anti-inflammatory drugs in chemotherapy.

  2015cited by this paper
• Potency of non-steroidal anti-inflammatory drugs in chemotherapy (Review)

  2015cited by this paper
• Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis

  2015cited by this paper
• Hitting the Bull’s-Eye in Metastatic Cancers—NSAIDs Elevate ROS in Mitochondria, Inducing Malignant Cell Death

  2015cited by this paper
• Doxorubicin combined with celecoxib inhibits tumor growth of medullary thyroid carcinoma in xenografted mice

  2014cited by this paper
• Histopathology and Immunohistochemical Expression of N-Methyl-N-Nitrosourea (NMU) Induced Mammary Tumours in Sprague-Dawley Rats

  2014cited by this paper
• d-limonene suppresses doxorubicin-induced oxidative stress and inflammation via repression of COX-2, iNOS, and NFκB in kidneys of Wistar rats

  2014cited by this paper
• COX-2–Independent Effects of Celecoxib Sensitize Lymphoma B Cells to TRAIL-Mediated Apoptosis

  2014cited by this paper
• In vitro effects of doxorubicin and deracoxib on oxidative-stress-related parameters in canine mammary carcinoma cells.

  2014cited by this paper
• A microfluidic system to study the cytotoxic effect of drugs: the combined effect of celecoxib and 5-fluorouracil on normal and cancer cells

  2013cited by this paper
• Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies.

  2012cited by this paper
• Combinatorial drug therapy for cancer in the post-genomic era

  2012cited by this paper
• The Effects of Piroxicam and Deracoxib on Canine Mammary Tumour Cell Line

  2012influential reference
• Antitumor effects of deracoxib treatment in 26 dogs with transitional cell carcinoma of the urinary bladder.

  2011cited by this paper
• Recent advances in apoptosis, mitochondria and drug resistance in cancer cells.

  2011influential reference
• Isolation, culture and analysis of mouse mammary epithelial cells.

  2010cited by this paper
• Plasma Membrane Proteomics and Its Application in Clinical Cancer Biomarker Discovery*

  2010cited by this paper
• 565 In vitro effects of doxorubicin and deracoxib on oxidative stress-related parameters in canine mammary carcinoma cells

  2010influential reference
• Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer.

  2009cited by this paper
• Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.

  2009influential reference
• Anti-Inflammatory Agents for Cancer Therapy.

  2009influential reference
• Safety and tolerability of 3-week and 6-month dosing of Deramaxx (deracoxib) chewable tablets in dogs.

  2009influential reference
• Inflammatory mammary carcinoma in 12 dogs: clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment.

  2009cited by this paper
• Influence of Catechol-O-Methyltransferase (COMT) Genotypes on the Prognosis of Canine Mammary Tumors

  2009cited by this paper
• Anticancer Drug Development

  2009cited by this paper
• Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond.

  2008cited by this paper
• Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells.

  2008cited by this paper
• Novel cytotoxic drugs: old challenges, new solutions.

  2008cited by this paper
• Anti-inflammatory activity of mangostins from Garcinia mangostana.

  2008cited by this paper
• Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation.

  2007cited by this paper
• Apoptosis: A Review of Programmed Cell Death

  2007cited by this paper
• In vitro effects of meloxicam with or without doxorubicin on canine osteosarcoma cells.

  2006influential reference
• Postoperative adjuvant treatment of invasive malignant mammary gland tumors in dogs with doxorubicin and docetaxel.

  2006cited by this paper
• Celecoxib Inhibits Prostate Cancer Growth: Evidence of a Cyclooxygenase-2-Independent Mechanism

  2005cited by this paper
• Non‐steroidal anti‐inflammatory drugs for the prevention and treatment of cancer

  2005cited by this paper
• Original Contribution EFFICACY AND TOXICITY OF DOXORUBICIN AND CYCLOPHOSPHAMIDE CHEMOTHERAPY IN DOGS WITH SPONTANEOUS MAMMARY TUMOURS

  2005cited by this paper
• Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide.

  2005cited by this paper
• Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method.

  2005cited by this paper
• In vivo effect of celecoxib and tenoxicam on oxidant/ anti-oxidant status of patients with knee osteoarthritis.

  2005cited by this paper
• Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease.

  2004cited by this paper
• The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumour: does celecoxib enhance the anti-tumour activity of doxorubicin?

  2004cited by this paper
• The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro

  2003cited by this paper
• Celecoxib: a specific COX-2 inhibitor with anticancer properties.

  2002cited by this paper
• Association of nitric oxide production and apoptosis in a model of experimental nephropathy.

  2001cited by this paper
• A structural view of mitochondria-mediated apoptosis

  2001cited by this paper
• Adjuvant post-operative chemotherapy in bitches with mammary cancer.

  2001cited by this paper
• Neuroprotective effects of non‐steroidal anti‐inflammatory drugs by direct scavenging of nitric oxide radicals

  2001influential reference
• Modulation of anthracycline activity in canine mammary tumour cells in vitro by medroxyprogesterone acetate.

  2000cited by this paper
• Chemotherapeutic evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model.

  2000cited by this paper
• Aspirin inhibits inducible nitric oxide synthase expression and tumour necrosis factor‐α release by cultured smooth muscle cells

  1999cited by this paper
• Inhibitory effects of indomethacin on interleukin-1 and nitric oxide production in rat microglia in vitro.

  1999cited by this paper
• Salicylate or aspirin inhibits the induction of the inducible nitric oxide synthase in rat cardiac fibroblasts.

  1996cited by this paper
• H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor.

  1993cited by this paper
• Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.

  1991cited by this paper
• Biologic properties of cell lines derived from canine mammary carcinomas.

  1986cited by this paper
• Cancer Chemotherapy

  1968cited by this paper

• Fucoxanthin Exerts Anti-Tumor Activity on Canine Mammary Tumor Cells via Tumor Cell Apoptosis Induction and Angiogenesis Inhibition

  2021cites this paper
• Perspective directions of conservative treatment of bitches with breast tumors (review information)

  2020cites this paper
• The Role of Glucocorticoids and NSAIDs in Cancer Treatment for Dogs and Cats

  year unknowncites this paper